A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis
Completed · Phase 2 · Has a placebo group
Conditions studied: Psoriatic Plaque
In brief
The study is designed to investigate efficacy and safety of KBL697 in patients with Moderate Plaque Type Psoriasis. KBL697 has been developed as a potential new treatment for Psoriatic Plaque.
Key facts
- Study ID
- NCT04911751
- Run by
- KoBioLabs
- People needed
- 80
- Starts
- 2021-11-08
- Expected to finish
- 2024-10-07
- Last updated by the study team
- 2025-01-07
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female, aged 18 to 75 years (inclusive)
- Have a diagnosis of plaque type psoriasis for ≥ 6 months
- Must have chronic plaque type psoriasis of moderate severity
- All subjects must agree and commit to the use of a reliable contraceptive regimen.
You may not qualify if…
- Current diagnosis of forms of psoriasis other than chronic plaque type only
- Drug-induced psoriasis
- Other inflammatory skin disease that may confound the evaluation of plaque psoriasis
- Failed 2 or more systemic treatments for plaque psoriasis
- Medicinal shampoos that contain tar and/or salicylic acid within 2 weeks prior to Baseline Visit
Where it is running
- Total Skin and Beauty Dermatology Center — Birmingham, Alabama, United States
- Southern California Dermatology, Inc — Santa Ana, California, United States
- Clinical Science Institute — Santa Monica, California, United States
- Revival Research Institute — Doral, Florida, United States
- Indago Research and Health Center — Hialeah, Florida, United States
- Louisiana Dermatology Associates - Dermatology — Baton Rouge, Louisiana, United States
- Premier Specialist — Kogarah, New South Wales, Australia
- Westmead Hospital — Westmead, New South Wales, Australia
- Veracity Clinical Trials Ltd — Woolloongabba, Queensland, Australia
- Sinclair Dermatology — East Melbourne, Victoria, Australia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.